Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs sodium thiopental anesthesia during ECT for major depressive disorder
IRCT20241203063932N1Phase 2Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine and thiopental in major depressive disorder (MDD) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Change in depression severity and Change in suicidal ideation. Started Aug 2025; status: completed.
02
Drugs
ketaminethiopental
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20241203063932N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241203063932N1.